Literature DB >> 16802129

Clonal variability of group B Streptococcus among different groups of carriers in southern Israel.

D Marchaim1, S Efrati, R Melamed, L Gortzak-Uzan, K Riesenberg, R Zaidenstein, F Schlaeffer.   

Abstract

A high prevalence of maternal group B Streptococcus (GBS) carriage and an extremely low incidence of invasive neonatal disease have been reported from southern Israel. In order to obtain insight into this discrepancy, this study was performed to determine the population structure of GBS from asymptomatic pregnant women living in this area. Seventy-two strains from maternal GBS carriers were characterized using multilocus sequence typing (MLST). Epidemiologic characteristics of the carriers and their newborns, including demographic variables, obstetric status, and general health parameters, were collected by means of a postpartum interview and a review of the relevant medical records. The MLST analysis grouped the bacteria into six different lineages (clonal complexes). Lineage ST-2 was prevalent among Bedouin-Arabs (p=0.01) and lineage ST-22 among Jews (p=0.001). Lineage ST-17 was prevalent among carriers who emigrated after 1997 from western nations of the former USSR (p<0.001). Lineage ST-22 was associated with carriage of surface-protein C (p=0.01) and lineage ST-17 with surface-protein R (p<0.01). Lineage ST-2 was prevalent among consumers of antibiotics (p=0.02) and was associated with erythromycin-resistant strains (p<0.001). Each subgroup of the southern Israeli maternal population has a different distribution of GBS clones. The clones prevalent among the Bedouin-Arabs and the Jews are known to be of low virulence. Lineage ST-17, which is associated with invasive disease, is prevalent among women who emigrated from western Soviet nations. Therefore, a different policy of GBS prophylaxis, resembling the one executed in endemic areas, should be considered in this population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802129     DOI: 10.1007/s10096-006-0163-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  Sequence type analysis and recombinational tests (START).

Authors:  K A Jolley; E J Feil; M S Chan; M C Maiden
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

2.  A prospective study of neonatal sepsis and meningitis in southern Israel.

Authors:  D Greenberg; E S Shinwell; P Yagupsky; S Greenberg; E Leibovitz; M Mazor; R Dagan
Journal:  Pediatr Infect Dis J       Date:  1997-08       Impact factor: 2.129

3.  Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.

Authors:  K Hordnes; T Tynning; A I Kvam; L Bevanger; T A Brown; R Jonsson; B Haneberg
Journal:  Scand J Immunol       Date:  1998-02       Impact factor: 3.487

4.  Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.

Authors:  C Larsson; M Stålhammar-Carlemalm; G Lindahl
Journal:  Vaccine       Date:  1999-02-05       Impact factor: 3.641

Review 5.  Concepts and controversies in the management of group B streptococcus during pregnancy.

Authors:  J C Glantz; K E Kedley
Journal:  Birth       Date:  1998-03       Impact factor: 3.689

Review 6.  Group B streptococcus.

Authors:  A Schuchat
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

7.  Cell wall proteins of group B Streptococcus and low incidence of neonatal disease in southern Israel.

Authors:  Dror Marchaim; Mordechai Hallak; Limor Gortzak-Uzan; Nechama Peled; Klaris Riesenberg; Francisc Schlaeffer
Journal:  J Reprod Med       Date:  2003-09       Impact factor: 0.142

8.  Risk factors for carriage of group B streptococcus in southern Israel.

Authors:  Dror Marchaim; Mordechai Hallak; Limor Gortzak-Uzan; Nechama Peled; Klaris Riesenberg; Francisc Schlaeffer
Journal:  Isr Med Assoc J       Date:  2003-09       Impact factor: 0.892

9.  Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-05-31

10.  Multilocus sequence typing system for group B streptococcus.

Authors:  Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more
  7 in total

1.  O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence.

Authors:  Shannon Weiman; Satoshi Uchiyama; Feng-Ying C Lin; Donald Chaffin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

Review 2.  Health and morbidity among Bedouin women in southern Israel: a descriptive literature review of the past two decades.

Authors:  Yulia Treister-Goltzman; Roni Peleg
Journal:  J Community Health       Date:  2014-08

3.  Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.

Authors:  Jenny Herbert; Stephen Thomas; Charlotte Brookes; Claudia Turner; Paul Turner; Francois Nosten; Kirsty Le Doare; Michael Hudson; Paul T Heath; Andrew Gorringe; Stephen Taylor
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

4.  High Incidence of Pathogenic Streptococcus agalactiae ST485 Strain in Pregnant/Puerperal Women and Isolation of Hyper-Virulent Human CC67 Strain.

Authors:  Liping Li; Rui Wang; Yan Huang; Ting Huang; Fuguang Luo; Weiyi Huang; Xiuying Yang; Aiying Lei; Ming Chen; Xi Gan
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

5.  Population structure of human isolates of Streptococcus agalactiae from Dakar and Bangui.

Authors:  Mathieu Brochet; Elisabeth Couvé; Raymond Bercion; Jean-Marie Sire; Philippe Glaser
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

6.  Serotype IX, a Proposed New Streptococcus agalactiae Serotype.

Authors:  Hans-Christian Slotved; Fanrong Kong; Lotte Lambertsen; Susanne Sauer; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

7.  Genetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area.

Authors:  Codruţa-Romaniţa Usein; Mădălina Militaru; Violeta Cristea; Monica Străuţ
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-03-05       Impact factor: 2.743

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.